Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer

Resolution Bioscience announces successful collaboration on a novel, non-invasive, targeted NGS test for lung cancer
Seattle, Washington (PRWEB) April 16, 2015 Dana-Farber Cancer Institute and its Belfer Institute for Applied Cancer Science and Resolution Bioscience, Inc. today announced the successful completion of a collaborative agreement to co-develop a novel, blood-based, clinic ready, Next Generation Sequencing (NGS) assay for non-small cell lung cancer (NSCLC). The collaboration is the first to demonstrate ...